Denis Talbot

Duration of Chemotherapy in Advanced Non–Small-Cell Lung Cancer: A Randomized Trial of Three Versus Six Courses of Mitomycin, Vinblastine, and Cisplatin

Ian E. Smith, Mary O’Brien, Denis Talbot et al. · Journal of Clinical Oncology · 2001 · 311 citations

Randomized Phase II Study of Dacomitinib (PF-00299804), an Irreversible Pan–Human Epidermal Growth Factor Receptor Inhibitor, Versus Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer

Suresh S. Ramalingam, Fiona Blackhall, Maciej Krzakowski et al. · Journal of Clinical Oncology · 2012 · 265 citations · Full text

A randomized, crossover, head-to-head comparison of eicosapentaenoic acid and docosahexaenoic acid supplementation to reduce inflammation markers in men and women: the Comparing EPA to DHA (ComparED) Study

Janie Allaire, Patrick Couture, Myriam Leclerc et al. · American Journal of Clinical Nutrition · 2016 · 247 citations · Full text

Inflammation, Anti-inflammatory, Inflammation Markers +6

Isolation of a small molecule inhibitor of DNA base excision repair

Srinivasan Madhusudan, Frank W. Smart, Paul J. Shrimpton et al. · Nucleic Acids Research · 2005 · 237 citations · Full text

A Phase II Study of Etanercept (Enbrel), a Tumor Necrosis Factor α Inhibitor in Patients with Metastatic Breast Cancer

Srinivasan Madhusudan, Martin D. Foster, S. Muthuramalingam et al. · Clinical Cancer Research · 2004 · 203 citations · Full text